These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10849876)

  • 1. Nonsustained ventricular tachycardia.
    Buxton AE; Duc J; Berger EE; Torres V
    Cardiol Clin; 2000 May; 18(2):327-36, viii. PubMed ID: 10849876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia. A guide to the clinical significance and management.
    Weigner MJ; Buxton AE
    Med Clin North Am; 2001 Mar; 85(2):305-20, x. PubMed ID: 11233950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia in dilated cardiomyopathy.
    Cuoco FA; Singh SN
    Curr Cardiol Rep; 2005 Sep; 7(5):368-75. PubMed ID: 16105493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The top ten fallacies of nonsustained ventricular tachycardia.
    Marinchak RA; Rials SJ; Filart RA; Kowey PR
    Pacing Clin Electrophysiol; 1997 Nov; 20(11):2825-47. PubMed ID: 9392814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and treatment of nonsustained ventricular tachycardia.
    Wilber DJ
    Curr Opin Cardiol; 1996 Jan; 11(1):23-31. PubMed ID: 8664529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems in everyday practice: ventricular extrasystoles].
    Schoels W; Bethge KP; Brachmann J; Gonska BD; Jung W; Wehr M
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1245-8. PubMed ID: 11687986
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation.
    Vohra J; Sathe S; Warren R; Tatoulis J; Hunt D
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):387-93. PubMed ID: 7681188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
    Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
    Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
    Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.
    Maron BJ
    Curr Cardiol Rep; 2000 Nov; 2(6):522-8. PubMed ID: 11060579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 16. Multimodality Cardiac Imaging in the Evaluation of a Patient with Near-Fatal Arrhythmia.
    Ngiam N; Chew N; Chai P; Poh KK
    Ann Acad Med Singap; 2019 Jan; 48(1):39-41. PubMed ID: 30788494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mitral valve prolapse and sudden death: a case report].
    Mokaddem A; Sdiri W; Makni H; Bachraoui K; Selmi K; Kachboura S; Boujnah MR
    Tunis Med; 2002 Jun; 80(6):349-51. PubMed ID: 12534049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiomyopathies: mortality, sudden death, and ventricular arrhythmias.
    Leier CV
    Cardiovasc Clin; 1992; 22(1):275-306. PubMed ID: 1728430
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitral valve prolapse: a source of arrhythmias?
    van der Wall EE; Schalij MJ
    Int J Cardiovasc Imaging; 2010 Feb; 26(2):147-9. PubMed ID: 20175294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.